Funding successes: January 2024

View of greens trees and South Kensington Campus from Exhibition Road

Congratulations to all members of the Department who have recently been awarded research grants. Here is our round-up of the latest funding successes.

Please note, this list comprises awards that have recently been set up on College’s grants management system, with some manual additions. It may not, therefore, include all new grants awarded to Principal Investigators in the Department.

Project Lead Co-Investigator(s) Funder Combined Scheme Project Title Amount
Goedele Maertens MRC Medical Research Council (MRC) Infections and immunity research Linking the HTLV-1 pre-integration complex to the chromatin £983,600
Andrew Edwards Gerald Larrouy-Maumus BBSRC Biotechnology and Biological Sciences Research Council Responsive mode research grants PA7700 Determining how polymyxins kill bacteria £616,800
Darius Armstrong-James Wendy Barclay, Cecilia Johansson MRC Medical Research Council (MRC) Tackling Emerging Co-Infections Comparative analysis of post-viral fungal pneumonia in influenza and SARS-Cov2 infected rodents £24,000
Robin Shattock John Tregoning, Nilay Shah, Karen Polizzi, Cleo Kontoravdi, Maria Papathanasiou, Rongjun Chen, Talia Shmool, Jason Hallett, Molly Stevens, David Peeler EPSRC Engineering & Physical Sciences Research Council Vaccines Manufacturing Research Hubs Future vaccine manufacturing hub : Accelerating the manufacture and deployment of cost effective vaccines (DHSC) £10,500,000
Alan Winston-O’keefe Jasmini Alagaratnam Gilead Sciences Inc Gilead’s Research Scholars Program in HIV: Early career investigators in the Europe, Canada and Australia Associations between plasma biomarkers and longitudinal changes in cognitive function: The POPPY study £100,000
James Seddon European and Developing Countries Clinical Trial Partnership Research and Innovation actions supporting the global health EDCTP3 Joint Undertaking Validation of treatment decision algorithms €5,400,000
Tom Parks Evangelos Bellos US Centres for Disease Control and Prevention Vanderbilt University Medical Center Default Scheme PA3676: Host genetic susceptibility to group A streptococcal necrotising fasciitis and toxic shock syndrome £57,612
Tom Parks Shiranee Sriskandan, Myrsini Kaforou ,Michael Levin Leducq Foundation 2021-2022 ARF BIOMARKER PROJECT PA2266: Acute Rheumatic Fever Diagnostic Collaborative (ARC) Network £396,348